Table 5. Multiple logistic regression model exploring factors associated with >50% seizures reduction at month 4.
| Variables | OR | 95% CI | p-value | |
|---|---|---|---|---|
| Phenobarbital + ivermectin | 1.177 | 0.707 | 1.960 | 0.530 |
| Phenobarbital alone (reference) | ||||
| Female | 0.938 | 0.563 | 1.564 | 0.807 |
| Male (reference) | ||||
| Age | 1.219 | 1.046 | 1.420 | 0.011 |
| Weight (in kg) | 0.972 | 0.912 | 1.036 | 0.385 |
| Total number of seizures at baseline | 1.080 | 0.984 | 1.185 | 0.104 |
| Nodding seizures | 1.250 | 0.437 | 3.572 | 0.678 |
| Other form of epilepsy (reference) | ||||
| Duration of epilepsy (years) | 0.813 | 0.701 | 0.943 | 0.006 |
| Dose of AED at baseline | 1.073 | 1.023 | 1.125 | 0.004 |
| Number of days without AED during the 4th month | 0.920 | 0.822 | 1.029 | 0.146 |
| Microfilarial density at baseline | 1.001 | 0.994 | 1.008 | 0.783 |
AED: Anti-epileptic drug; OR: Odds Ratio; CI: Confidence Interval